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Neostigmine-induced bronchospasm is extremelly rare in everyday anesthesia 
practice. We report a case of a life-threatening acute bronchospasm associated with a 
routine reversal of neuromuscular blockade in a 48-year-old man who underwent a 
ventral hernia repair under general anesthesia. Thirty seconds after, neostigmine
 was 
administered with the aim to reverse the rocuronium-induced neuromuscular blockade, 
the symptoms of severe bronchospasm occured, including increased peak inspiratory 
pressure, oxygen desaturation and decreased tidal volumes. Auscultation of the lungs 
revealed bilateral loud wheezes throughout. Bronchospasm was sucessefuly treated with 
high ispiratory concentrations of sevoflurane (7%), 100% oxygen, methylprednisolon 
and aminophylline. It is important that anesthetists are aware of the potential 
bronchoconstriction potency of neostigmine. Sevoflurane and glucocorticoids may be 
useful in the treatment of bronchospasm caused by neostigmine. Acta Medica Medianae 
2006; 45(3):53-55. 
 
Key words: bronchospasm, neostigmine, acetylcholine, muscarinic receptors 
 
 
Surgical Clinic Clinical Center of Nis 
 
Correspondence to: Radmilo Jankovic 
Surgical Clinic Clinical Center  
48 dr Zoran Djindjic Street 
18000 Nis, Serbia 
Phone: +38118329503 
E-mail: jradmilo@eunet.yu 
 
 
Introduction 
 
During general anesthesia administration, 
bronchospasm may have many etiologies, inclu-
ding the patient's intrinsic disease and mecha-
nical, chemical or neurogenic causes. Although is 
possible, anticholinesterase- induced broncho-
spasm is extremelly rare in everyday anesthesia 
practice.
  We present a case of the life-threate-
ning acute bronchospasm induced by routine 
reversal of neuromuscular blockade (NMB), suc-
cessfully treated with sevoflurane, aminophylline 
and glucocorticoids. 
 
Case report 
 
A 48-year-old man underwent a ventral 
hernia repair during general anesthesia admini-
stration. His preoperative medical history was 
significant for long smoking history (30 cigaretes 
per day) and obesity. The patient denied any 
history of allergy, chronic lung diseases or use of 
any medications. No pulmonary function tests 
were done preoperatively. Anesthesia was indu-
ced with propofol 2mg
.kg
-1 and fentanyl 3 µg
.kg
-1. 
A 8.5-mm ID cuffed endotracheal tube (ETT) was 
placed without difficulty under muscle relaxation  
achieved with intermittent administration of 
rocuronium under neuromuscular monitoring. 
Anesthesia was maintained with nitrous oxide, 
oxygen and sevoflurane (end tidal concentration 
stable at 2%). There were no signs of respiratory 
obstruction intraoperatively. The surgery proce-
eded uneventfully and was completed within ap-
proximately 30 min. Thirty seconds after 1 mg 
atropine and 2.5 mg neostigmine
 were adminis-
tered with the aim to reverse the rocuronium 
induced NMB, the peak inspiratory pressure (PIP) 
increased suddenly from 19 - 22 mmHg to 50 - 
55 mmHg with decreased tidal volumes. The O2 
saturation decreased to 72% and auscultation of 
the lungs revealed bilateral loud wheezes throu-
ghout. Mechanical ventilation was discontinued 
and the patient was ventilated by hand with 
100% O2 and 2% sevoflurane. No compression of 
the ETT or trachea was found. With the aim to 
ensure patency of the ETT, a suction catheter 
was passed into the ETT and there were no 
secretions or aspirate. The heart rate increased 
up dramatically from 88 to 135 beats·min
-1. Mean 
arterial pressure remained unchanged. An initial 
250 mg of methylprednisolon and 5 mg
.kg
-1 
aminophylline over the next 10 min were given. 
However, 10 minutes after, there was no impro-
vement in symptoms. With agravated haemo-
dynamical status, sevoflurane inhalation was inc-
reased immediately up to 7%, and aditional bolus A case of life-treathening acute bronchospasm induced by routine...                  Radmilo Janković i sar. 
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of 250 mg methylprednisolon was administered. 
The O2 saturation increased to 96% within 
approximately 40 s and to 100% a few minutes 
later on 100% O2 and 2.5 % sevoflurane. The 
patient was placed back on the ventilator and   
PIP decreased to 22 mmHg. Auscultation of the 
chest revealed clear breath sounds throughout 
and heart rate decreased to the patient's baseline 
90 beats·min
-1. About 20 minutes after it was 
started, sevoflurane inhalation was discontinued. 
The patient was stable and was extubated 
successfully 25 min after this episode. Blood was 
sent for immunoglobulin E (IgE) and serum mast 
cell tryptase, and both values were normal: IgE-
86 (IU)/mL (normal = 0 to 120 IU/mL), serum 
tryptase <1 ng/mL (normal = <10 ng/mL). 
 
Discussion 
 
Neostigmine is an anticholinesterase drug 
frequently used for reversal of nondepolarising     
NMB. The clinical features and the time of the 
reaction onset were highly suggestive of neostig-
mine- induced bronchospasm. Serum IgE and 
mast cell tryptase values were normal, excluding 
anaphylaxis as the cause of the bronchospasm. 
We believe that intravenous administration of 
neostigmine caused bronchospasm, as the result 
of its parasympathomimetic action. Increased 
release of acetylcholine(ACh) induced by anticho-
linesterase activity of neostigmine can contribute 
to increases in airway responsiveness. Neostig-
mine also potentiated serotonin-induced broncho-
constriction, supporting ACh release upon sti-
mulation of  serotonin (1). ACh stimulates both 
M3 muscarinic receptors on the airway
  smooth 
muscle, causing contraction and broncho-
constriction, and
 M2 muscarinic receptors on the 
nerves, decreasing further release
  of acetyl-
choline. Atropine is an anticholinergic drug widely 
used to reverse the muscarinic effects of neostig-
mine during routine reversal of NMB. However, 
atropine is a non-selective muscarinic antagonist, 
which blocks both prejunctional M2-receptors and 
postjunctional
  M3-receptors on the smooth 
muscle with equal efficacy. Therefore, it
 increases 
ACh release, which may then overcome the 
postjunctional
 blockade. This means that  atropi-
ne will not be fully effective
 against Ach- induced 
bronchoconstriction (2). 
Aminophylline and glucocorticoids are com-
monly used for the treatment of acute broncho-
spasm. The beneficial
 effects are based on
 anti-
inflammatory properties of these medications. 
Glucocorticoid treatment also decreases airway 
responsiveness to ACh via two mechanisms: in-
creased
  M2 receptor function and increased de-
gradation of acetylcholine
 by cholinesterases. Their 
effects are mediated by the activation of gluco-
corticoid
 receptors  in target cells in the lung (3). 
Volatile anesthetic agents have been repor-
ted to produce bronchodilatation in patients su-
ffering from bronchospasm (4). Sevoflurane has 
a more marked ability to decrease respiratory 
resistance than isoflurane, halothane, or thiopen-
tal-nitrous oxide (5). In patients with positive 
smoking status, sevoflurane causes significant 
decreases in Rrs (6). Sevoflurane reduced the 
airway smooth muscle tone probably by inhibition 
of Ach release and by direct interference with the 
intracellular contractile processes of the airway 
smooth muscle cells (7).  
 
Conclusion 
 
It is important that anesthetists are aware 
of the potential bronchoconstriction potency of 
neostigmine. Sevoflurane and glucocorticoids 
may be useful in the treatment of bronchospasm 
caused by neostigmine. 
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PRIKAZ SLUČAJA AKUTNOG I PO ŽIVOT OPASNOG BRONHOSPAZMA 
PROVOCIRANOG RUTINSKOM REVERZIJOM NEUROMIŠIĆNE 
BLOKADE 
 
Radmilo Janković, Biljana Stošić, Dragana Djordjević i Dragana Todorović 
 
 
Bronhospazam, prouzrokovan neostigminom, izuzetno je redak u svakodnevnoj 
anesteziološkoj praksi. Mi prikazujemo slučaj po život opasnog akutnog bronhospazma 
udruženog sa rutinskom reverzijom neuromišićne blokade kod četrdesetjednogodišnjeg 
muškarca, koji se podvrgao operaciji kile, prednjeg trbušnog zida u opštoj anesteziji. 
Trideset sekundi nakon što je neostigmin primenjen, sa ciljem reverzije rokuronijumom 
izazvanog neoromišićnog bloka, razvili su se simptomi akutnog bronhospazma 
uključujući: povišeni vršni inspiratorni pritisak, kiseoničnu desaturaciju i smanjenje 
disajnih volumena. Auskultacijom pluća  čulo se bilateralno glasno zviždanje. 
Bronhospazam je uspešno tretiran visokim inspiratornim koncentracijama sevoflurana 
(7%),  čistim kiseonikom, metilprednizolonom i aminofilinom. Za anesteziologe je 
naročito važno da budu svesni bronhokonstriktorno provocirajućeg efekta neostigmina. 
Sevofluran i glukokortikoidi mogu biti od koristi u tretmanu bronhospazma izazvanog 
neostigminom. Acta Medica Medianae 2006; 45(3):53-55. 
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